Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Serum Hepcidin Response After Intravenous Iron Therapy

NCT06264687 is registered in ClinicalTrials.gov with Pierre-Alexandre Krayenbühl as lead sponsor.

NCT NCT06264687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06264687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Serum Hepcidin Response After Intravenous Iron Therapy
Lead sponsor
Pierre-Alexandre Krayenbühl
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2024
Completion date
May 31, 2024
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

iron deficiency (without anemia)